Causal reasoning over knowledge graphs leveraging drug-perturbed and disease-specific transcriptomic signatures for drug discovery
Table 1
Evaluation of RPath in multiple datasets across the two KGs using precision.
Each row corresponds to the results of running RPath on a specific drug-disease dataset combination. The second and fourth columns show the performance that is expected to be achieved by chance.